Lacosamide is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Natco Pharma Limited. The primary component is Lacosamide.
Product ID | 63850-0055_f7121f99-b30f-4286-aac0-bc9b59eb0e59 |
NDC | 63850-0055 |
Product Type | Human Prescription Drug |
Proprietary Name | Lacosamide |
Generic Name | Lacosamide |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2016-05-28 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA204921 |
Labeler Name | Natco Pharma Limited |
Substance Name | LACOSAMIDE |
Active Ingredient Strength | 150 mg/1 |
Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
DEA Schedule | CV |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2016-05-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA204921 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-05-28 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA204921 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-05-28 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
LACOSAMIDE | 150 mg/1 |
SPL SET ID: | f7121f99-b30f-4286-aac0-bc9b59eb0e59 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0121-0992 | Lacosamide | Lacosamide |
0121-1984 | Lacosamide | Lacosamide |
0121-2976 | Lacosamide | Lacosamide |
0121-3968 | Lacosamide | Lacosamide |
63850-0055 | Lacosamide | Lacosamide |
63850-0053 | Lacosamide | Lacosamide |
63850-0054 | Lacosamide | Lacosamide |
63850-0056 | Lacosamide | Lacosamide |
65162-912 | Lacosamide | Lacosamide |
0131-1810 | Vimpat | lacosamide |
0131-2470 | Vimpat | lacosamide |
0131-2477 | Vimpat | lacosamide |
0131-2478 | Vimpat | lacosamide |
0131-2479 | Vimpat | lacosamide |